Cargando…

Health-related quality of life as predictor of mortality in end-stage renal disease patients: an observational study

BACKGROUND: Health-related quality of life (HRQoL) is an important component of patient-centered outcomes and a useful parameter for monitoring quality of care. We assessed HRQoL, its determinants, and associations with mortality in patients with end-stage renal disease (ESRD). METHODS: Short Form-3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pei, Ming, Aguiar, Rute, Pagels, Agneta A., Heimbürger, Olof, Stenvinkel, Peter, Bárány, Peter, Medin, Charlotte, Jacobson, Stefan H., Hylander, Britta, Lindholm, Bengt, Qureshi, Abdul Rashid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489294/ https://www.ncbi.nlm.nih.gov/pubmed/31035977 http://dx.doi.org/10.1186/s12882-019-1318-x

Ejemplares similares

Interleukin-6-to-Albumin Ratio as a Superior Predictor of Mortality in End-Stage Kidney Disease Patients
por: Li, Xiejia, et al.
Publicado: (2023)

Clinical global assessment of nutritional status as predictor of mortality in chronic kidney disease patients
por: Dai, Lu, et al.
Publicado: (2017)

Delta-He: a novel marker of inflammation predicting mortality and ESA response in peritoneal dialysis patients
por: Danielson, Kristin, et al.
Publicado: (2014)

The higher mortality associated with low serum albumin is dependent on systemic inflammation in end-stage kidney disease
por: Alves, Filipa Caeiro, et al.
Publicado: (2018)

Differences in association of lower bone mineral density with higher coronary calcification in female and male end-stage renal disease patients
por: Chen, Zhimin, et al.
Publicado: (2019)

Restrictive lung disorder is common in patients with kidney failure and associates with protein-energy wasting, inflammation and cardiovascular disease
por: Mukai, Hideyuki, et al.
Publicado: (2018)

Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease
por: Missailidis, Catharina, et al.
Publicado: (2016)

Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease
por: Machowska, Anna, et al.
Publicado: (2016)

Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease
por: Feldreich, Tobias, et al.
Publicado: (2018)

Copeptin is independently associated with vascular calcification in chronic kidney disease stage 5
por: Golembiewska, Edyta, et al.
Publicado: (2020)

Three-month variation of plasma pentraxin 3 compared with C-reactive protein, albumin and homocysteine levels in haemodialysis patients
por: Sjöberg, Bodil, et al.
Publicado: (2014)

Health-related quality of life in different stages of chronic kidney disease and at initiation of dialysis treatment
por: Pagels, Agneta A, et al.
Publicado: (2012)

Inflammation down-regulates CYP3A4-catalysed drug metabolism in hemodialysis patients
por: Molanaei, Hadi, et al.
Publicado: (2018)

Central obesity as assessed by conicity index and a-body shape index associates with cardiovascular risk factors and mortality in kidney failure patients
por: Ryu, Kakei, et al.
Publicado: (2023)

Bone mineral density and mortality in end-stage renal disease patients
por: Iseri, Ken, et al.
Publicado: (2020)

Selection of Genetic and Phenotypic Features Associated with Inflammatory Status of Patients on Dialysis Using Relaxed Linear Separability Method
por: Bobrowski, Leon, et al.
Publicado: (2014)

A cohort study of insulin-like growth factor 1 and mortality in haemodialysis patients
por: Nilsson, Erik, et al.
Publicado: (2016)

Chronic inflammation in end-stage renal disease and dialysis
por: Cobo, Gabriela, et al.
Publicado: (2018)

High-sensitivity troponins in dialysis patients: variation and prognostic value
por: Snaedal, Sunna, et al.
Publicado: (2020)

Associations between Thyroid Hormones, Calcification Inhibitor Levels and Vascular Calcification in End-Stage Renal Disease
por: Meuwese, Christiaan Lucas, et al.
Publicado: (2015)

Longitudinal genome-wide DNA methylation changes in response to kidney failure replacement therapy
por: Witasp, Anna, et al.
Publicado: (2022)

Functional vitamin K insufficiency, vascular calcification and mortality in advanced chronic kidney disease: A cohort study
por: Dai, Lu, et al.
Publicado: (2021)

Early Vascular Ageing and Cellular Senescence in Chronic Kidney Disease
por: Dai, Lu, et al.
Publicado: (2019)

Aortic Valve Calcium Associates with All-Cause Mortality Independent of Coronary Artery Calcium and Inflammation in Patients with End-Stage Renal Disease
por: Dai, Lu, et al.
Publicado: (2020)

Sclerostin─A Debutant on the Autosomal Dominant Polycystic Kidney Disease Scene?
por: Jankowska, Magdalena, et al.
Publicado: (2017)

Fractures and their sequelae in non-dialysis-dependent chronic kidney disease: the Stockholm CREAtinine Measurement project
por: Runesson, Björn, et al.
Publicado: (2019)

Blood–brain barrier and gut barrier dysfunction in chronic kidney disease with a focus on circulating biomarkers and tight junction proteins
por: Hernandez, Leah, et al.
Publicado: (2022)

Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly
por: Sjöberg, B., et al.
Publicado: (2015)

Angiotensin‐converting enzyme 2 and transmembrane protease serine 2 in female and male patients with end‐stage kidney disease
por: Arefin, Samsul, et al.
Publicado: (2022)

Incidence of Fractures Before and After Dialysis Initiation
por: Iseri, Ken, et al.
Publicado: (2020)

Causes of death across categories of estimated glomerular filtration rate: The Stockholm CREAtinine Measurements (SCREAM) project
por: Runesson, Björn, et al.
Publicado: (2019)

Sevelamer Use in End-Stage Kidney Disease (ESKD) Patients Associates with Poor Vitamin K Status and High Levels of Gut-Derived Uremic Toxins: A Drug–Bug Interaction?
por: Dai, Lu, et al.
Publicado: (2020)

Blood pressure and kidney outcomes in patients with severely decreased glomerular filtration rate: a nationwide observational cohort study
por: Al-Sodany, Ehab, et al.
Publicado: (2022)

Role of Uremic Toxins in Early Vascular Ageing and Calcification
por: Kyriakidis, Nikolaos C., et al.
Publicado: (2021)

Sarcopenia in chronic kidney disease: what have we learned so far?
por: Sabatino, Alice, et al.
Publicado: (2020)

Incidence, predictors and clinical management of hyperkalaemia in new users of mineralocorticoid receptor antagonists
por: Trevisan, Marco, et al.
Publicado: (2018)

Antibodies against Malondialdehyde in Haemodialysis Patients and Its Association with Clinical Outcomes: Differences between Subclasses and Isotypes
por: Samal, Shailesh Kumar, et al.
Publicado: (2020)

Ultraprocessed foods and chronic kidney disease—double trouble
por: Avesani, Carla Maria, et al.
Publicado: (2023)

Matrix Gla protein is an independent predictor of both intimal and medial vascular calcification in chronic kidney disease
por: Jaminon, Armand M. G., et al.
Publicado: (2020)

The Stockholm CREAtinine Measurements (SCREAM) project: protocol overview and regional representativeness
por: Runesson, Björn, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ghd1h6qqomchommrch3e4j16gj